CYSTEINE PROTEASE ACTIVATED BY EXPRESSION OF HIV-1 PROTEASE IN TRANSGENIC MICE - MIP26 (AQUAPORIN-0) CLEAVAGE AND CATARACT FORMATION IN-VIVO AND EX-VIVO
Kp. Mitton et al., CYSTEINE PROTEASE ACTIVATED BY EXPRESSION OF HIV-1 PROTEASE IN TRANSGENIC MICE - MIP26 (AQUAPORIN-0) CLEAVAGE AND CATARACT FORMATION IN-VIVO AND EX-VIVO, The Journal of biological chemistry, 271(50), 1996, pp. 31803-31806
Transgenic mice, homozygous for HIV-1 protease expression in the eye l
ens, display degradation of some lens crystallins and cytoskeletal pro
teins prior to cataract formation on postnatal days 23-25, Alterations
to the internal lens hydration state also occur; therefore, the statu
s of the aquaporin protein MIP26 was examined over postnatal days 16-2
5 to determine if it was altered during cataractogenesis. The MTP was
identical in transgenic and control lenses until day 21. By postnatal
day 25 (frank cataract), in the lenses obtained from transgenic animal
s, the 26-kDa band was absent and there was a concurrent increase in t
he proportion of MIP23, Immunoblotting demonstrated cleavage at the C
terminus, Lenses were also maintained in an organ culture system to de
monstrate that the cataractogenic process is inherent to the isolated
lens and to determine the contribution of cysteine protease action, Or
gan culture experiments revealed a similar progression to nuclear cata
ract formation as seen in vivo. Two-dimensional gel analysis of the so
luble lens crystallin fraction of organ cultured lenses revealed the s
ame cleavage pattern as occurs in vivo, Organ culture of transgenic le
nses with E64, a cysteine protease inhibitor, dramatically delayed cat
aractogenesis and prevented proteolytic cleavage of both MIP26 and cry
stallins, HIV-1 protease, while the trigger of cataract formation, doe
s not appear to be the protease responsible for cleavage of MIP or len
s crystallins. These results suggest that activation of endogenous cys
teine protease activity is involved in the cleavage of these proteins
and occurs downstream of HIV-1 protease action.